Abstract
Immunosuppressed children with cancer are constantly at risk of developing infections. The extent of susceptibility depends on the integrity of the various components of the immune system and the virulence and number of microbes to which the individual is exposed. Many other factors, including the type and stage of malignancy, type and extent of antimicrobial and anticancer therapies, integrity of the skin and mucous membranes, duration of hospitalization, and nutritional status also affect the risk of infection.
Preview
Unable to display preview. Download preview PDF.
References
Langley J, Gold R (1988) Sepsis in febrile neutropenic children with cancer. Pediatr Infect Dis J 7: 34–37
Pizzo PA, Ladisch S, Robichaud K (1980) Treatment of gram-positive septicemia in cancer patients. Cancer 45: 206–207
Wade JC, Schimpff SC, Newman KA, Wiernik PH (1982) Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 97: 503–508
Patrick CC (1990) Coagulase-negative staphylococci: pathogens with increasing clinical significance. J Pediatr 116: 497–507
Wade JC (1989) Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs monotherapy. Rev Infect Dis 11: S1572–S1581
Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DAG (1983) Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 2: 1452–1454
Sotiropoulos SV, Jackson MA, Woods GM, Hicks RA, Cullen J, Freeman AI (1989) Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J 8: 755–758
Shenep JL, Hughes WT, Roberson PK, Blankenship KR, Baker DK Jr, Meyer WH, Gigliotti F, Sixbey JW, Santana VM, Feldman S, Lott L (1988) Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med 319: 1053–1058
Johnson MP, Ramphai R (1990) ß-Lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J Infect Dis 162: 981–983
Whitby JL, Rampling A (1972) Pseudomonas aeruginosa contamination in domestic and hospital environments. Lancet 1: 15–17
Pilon VA, Echols RM, Celo JS, Elmendorf SL (1987) Disseminated Pneumocystis carinii infection in AIDS. N Engl J Med 316: 1410–1411
Masur H, Lane HC, Kovacs JA, Allegra CJ, Edman JC (1989) Pneumocystis pneumonia: from bench to clinic. Ann Intern Med 111: 813–826
Navin TR, Fontaine RE (1984) Intravenous versus intramuscular administration of pentamidine. N Engl J Med 311: 1701–1702
Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L (1987) Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 316: 1627–1632
Henson D, Siegel SE, Fuccillo DA, Matthew E, Levine AS (1972) Cytomegalovirus infections during acute childhood leukemia. J Infect Dis 126: 469–481
Reed EC, Bowdin RA, Dandliker PS, Lilleby KE, Meyers JD (1988) Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 109: 783–788
Emanuel D, Cunningham I, Jules-Elysee K, Brochstein JA, Kernan NA, Laver J, Stover D, White DA, Fels A, Polsky B, Castro-Malaspina H, Peppard JR, Bartus P, Hammerling U, O’Reilly RJ (1988) Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 109: 777–782
Feldman S, Hughes WT, Daniel CB (1975) Varicella in children with cancer: seventy-seven cases. Pediatrics 56: 388–397
Feldman S, Hughes WT, Kim HY (1973) Herpes zoster in children with cancer. Am J Dis Child 126: 178–184
Feldman S, Lott L (1987) Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 80: 465–472
Hughes WT (1982) Systemic candidiasis: a study of 109 fatal cases. Pediatr Infect Dis J 1: 11–18
Meunier F (1989) New methods for delivery of antifungal agents. Rev Infect Dis 11: S1605–S1612
Meunier F (1987) Prevention of mycoses in immunocompromised patients. Rev Infect Dis 9: 408–416
Bartley DL, Hughes WT, Parvey LS, Parham D (1982) Computed tomography of hepatic and splenic fungal abscesses in leukemic children. Pediatr Infect Dis J 1: 317–321
Thaler M, Pastakia B, Shawker TH, O’Leary T, Pizzo PA (1988) Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 108: 88–100
Yu, VL, Muder RR, Poorsattar A (1986) Significance of isolation of aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 81: 249–254
Denning DW, Stevens DA (1990) Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 12: 1147–1201
Denning DW, Tucker RM, Hanson LH, Stevens DA (1989) Treatment of invasive aspergillosis with itraconazole. Am J Med 86: 791–800
Schimpff S, Satterlee W, Young VM, Serpick A (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284: 1061–1065
Hughes WT, Armstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD, Pizzo PA, Schimpff SC, Shenep JL, Wade JC, Young LS, Yow MD (1990) Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 161: 381–396
Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328–340
Shenep JL (1990) Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis. NCI Monogr 9: 117–122
Flynn PM (1992) Vascular access device infections: In: Patrick CC (ed) Infections in immunocompromised infants and children. Churchill Livingston, New York (in apress)
Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO (1984) Hickman catheter infections in patients with malignancies. Medicine (Baltimore) 63: 189–200
Meyers JD (1986) Infection in bone marrow transplant recipients. Am J Med 81: 27–38
Engelhard D, Marks MI, Good RA (1986) Infections in bone marrow transplant recipients. J Pediatr 108: 335–346
Feldman S, Gigliotti F, Shenep JL, Roberson PK, Lott L (1990) Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. J Infect Dis 161: 926–931
Peter G (ed) (1988) Report of the Committee on Infectious Diseases, 21st edn. American Academy of Pediatrics, Elk Grove Village, Illinois, p 331
Walsh TJ, Schimpff SC (1983) Prevention of infection among patients with cancer. Eur J Cancer Clin Oncol 19: 1333–1344
Valdivieso M, Cabanillas F, Keating M, Barkley HT, Murphy WK, Burgess MA, Frazier H, Chen T, Bodey GP (1984) Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units. Am J Med 76: 405–412
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Flynn, P.M., Hughes, W.T. (1992). Infections in Immunocompromised Children. In: Voûte, P.A., Barrett, A., Lemerle, J. (eds) Cancer in Children. UICC International Union Against Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84722-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-84722-6_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84724-0
Online ISBN: 978-3-642-84722-6
eBook Packages: Springer Book Archive